{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:25:04Z","timestamp":1790857504939,"version":"4.1.0"},"reference-count":38,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T00:00:00Z","timestamp":1587600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>Helicobacter pylori (H. pylori) is a primary etiologic factor in gastric diseases. Sulglycotide is a glycopeptide derived from pig duodenal mucin. Esterification of its carbohydrate chains with sulfate groups creates a potent gastroprotective agent used to treat various gastric diseases. We investigated the inhibitory effects of sulglycotide on adhesion and inflammation after H. pylori infection in human gastric adenocarcinoma cells (AGS cells). H. pylori reference strain 60190 (ATCC 49503) was cultured on Brucella agar supplemented with 10% bovine serum. Sulgylcotide-mediated growth inhibition of H. pylori was evaluated using the broth dilution method. Inhibition of H. pylori adhesion to AGS cells by sulglycotide was assessed using a urease assay. Effects of sulglycotide on the translocation of virulence factors was measured using western blot to detect cytotoxin-associated protein A (CagA) and vacuolating cytotoxin A (VacA) proteins. Inhibition of IL-8 secretion was measured using enzyme-linked immunosorbent assay (ELISA) to determine the effects of sulglycotide on inflammation. Sulglycotide did not inhibit the growth of H. pylori, however, after six and 12 hours of infection on AGS cells, H. pylori adhesion was significantly inhibited by approximately 60% by various concentrations of sulglycotide. Sulglycotide decreased H. pylori virulence factor (CagA and VacA) translocation to AGS cells and inhibited IL-8 secretion. Sulglycotide inhibited H. pylori adhesion and inflammation after infection of AGS cells in vitro. These results support the use of sulglycotide to treat H. pylori infections.<\/jats:p>","DOI":"10.3390\/ijerph17082918","type":"journal-article","created":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T10:46:22Z","timestamp":1587638782000},"page":"2918","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The Effects of Sulglycotide on the Adhesion and the Inflammation of Helicobacter Pylori"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7141-8242","authenticated-orcid":false,"given":"Ji Yeong","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Biomedical Laboratory Science, College of Health Sciences, Yonsei University, Wonju 26493, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pumsoo","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Catholic Kwandong University International St. Mary\u2019s Hospital, Incheon 22711, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9197-1184","authenticated-orcid":false,"given":"Seok-Hoo","family":"Jeong","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Catholic Kwandong University International St. Mary\u2019s Hospital, Incheon 22711, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Woong","family":"Lee","sequence":"additional","affiliation":[{"name":"Samil Pharmaceutical Co. Ltd., Seoul 06666, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Sik","family":"Myung","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Catholic Kwandong University International St. Mary\u2019s Hospital, Incheon 22711, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myong Ki","family":"Baeg","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Catholic Kwandong University International St. Mary\u2019s Hospital, Incheon 22711, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6502-2281","authenticated-orcid":false,"given":"Jong-Bae","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Biomedical Laboratory Science, College of Health Sciences, Yonsei University, Wonju 26493, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,4,23]]},"reference":[{"key":"ref_1","unstructured":"(2011, March 28). Schistosomes, Liver Flukes and Helicobacter pylori. IARC Monogr. Eval. Carcinog. Risks Hum. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK487782\/pdf\/Bookshelf_NBK487782.pdf."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0016-5085(97)70075-1","article-title":"Helicobacter pylori infection and chronic gastric acid hyposecretion","volume":"113","author":"Oien","year":"1997","journal-title":"Gastroenterology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0016-5085(99)70121-6","article-title":"Duodenal Helicobacter pylori infection differs in cagA genotype between asymptomatic subjects and patients with duodenal ulcers","volume":"116","author":"Hamlet","year":"1999","journal-title":"Gastroenterology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1053\/j.gastro.2015.09.004","article-title":"Pathobiology of Helicobacter pylori-Induced Gastric Cancer","volume":"150","author":"Amieva","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1056\/NEJMra020542","article-title":"Helicobacter pylori infection","volume":"347","author":"Suerbaum","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1056\/NEJMoa001999","article-title":"Helicobacter pylori infection and the development of gastric cancer","volume":"345","author":"Uemura","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1523-5378.2007.00504.x","article-title":"Seroprevalence of Helicobacter pylori in South Korea","volume":"12","author":"Yim","year":"2007","journal-title":"Helicobacter"},{"key":"ref_8","first-page":"1063","article-title":"Induction of caspase-3 and nitric oxide synthase-2 during gastric mucosal inflammatory reaction to Helicobacter pylori lipopolysaccharide","volume":"46","author":"Slomiany","year":"1998","journal-title":"Biochem. Mol. Biol. Int."},{"key":"ref_9","first-page":"3","article-title":"Lipopolysaccharide a virulence factor of Helicobacter pylori: Effect of antiulcer agents","volume":"49","author":"Piotrowski","year":"1998","journal-title":"J. Physiol. Pharmacol."},{"key":"ref_10","first-page":"475","article-title":"Anti-Helicobacter pylori activities of ebrotidine. A review of biochemical and animal experimental studies and data","volume":"47","author":"Slomiany","year":"1997","journal-title":"Arzneimittelforschung"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1046\/j.1365-2958.2002.02781.x","article-title":"c-Src\/Lyn kinases activate Helicobacter pylori CagA through tyrosine phosphorylation of the EPIYA motifs","volume":"43","author":"Stein","year":"2002","journal-title":"Mol. Microbiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1126\/science.1067147","article-title":"SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein","volume":"295","author":"Higashi","year":"2002","journal-title":"Science"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1046\/j.1462-5822.2000.00043.x","article-title":"Translocation of the Helicobacter pylori CagA protein in gastric epithelial cells by a type IV secretion apparatus","volume":"2","author":"Backert","year":"2000","journal-title":"Cell. Microbiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nature05765","article-title":"Helicobacter pylori CagA targets PAR1\/MARK kinase to disrupt epithelial cell polarity","volume":"447","author":"Saadat","year":"2007","journal-title":"Nature"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nrc1433","article-title":"Oncogenic mechanisms of the Helicobacter pylori CagA protein","volume":"4","author":"Hatakeyama","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"ref_16","first-page":"951","article-title":"Induction of gastric epithelial cell apoptosis by Helicobacter pylori vacuolating cytotoxin","volume":"63","author":"Cover","year":"2003","journal-title":"Cancer Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"5080","DOI":"10.1128\/IAI.69.8.5080-5087.2001","article-title":"Vacuolating cytotoxin of Helicobacter pylori induces apoptosis in the human gastric epithelial cell line AGS","volume":"69","author":"Kuck","year":"2001","journal-title":"Infect. Immun."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"6361","DOI":"10.1093\/emboj\/19.23.6361","article-title":"The N-terminal 34 kDa fragment of Helicobacter pylori vacuolating cytotoxin targets mitochondria and induces cytochrome c release","volume":"19","author":"Galmiche","year":"2000","journal-title":"EMBO J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1046\/j.1365-2958.2000.02013.x","article-title":"Acid activation of Helicobacter pylori vacuolating cytotoxin (VacA) results in toxin internalization by eukaryotic cells","volume":"37","author":"McClain","year":"2000","journal-title":"Mol. Microbiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s10875-011-9626-3","article-title":"Interweaving microRNAs and proinflammatory cytokines in gastric mucosa with reference to H. pylori infection","volume":"32","author":"Isomoto","year":"2012","journal-title":"J. Clin. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1172\/JCI30111","article-title":"Inflammation, atrophy, and gastric cancer","volume":"117","author":"Fox","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_22","first-page":"745","article-title":"Characterization of gastric mucosal mucin receptor","volume":"31","author":"Slomiany","year":"1993","journal-title":"Biochem. Mol. Biol. Int."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1021\/ac50010a020","article-title":"Determination of trace metals in fresh water mussels by atomic absorption spectrometry with direct solid sample injection","volume":"49","author":"Lord","year":"1977","journal-title":"Anal. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/0306-3623(94)90105-8","article-title":"Inhibition of gastric mucosal mucin receptor by Helicobacter pylori lipopolysaccharide: Effect of sulglycotide","volume":"25","author":"Piotrowski","year":"1994","journal-title":"Gen. Pharmacol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0306-3623(98)00200-6","article-title":"Suppression of gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide by sulglycotide","volume":"32","author":"Slomiany","year":"1999","journal-title":"Gen. Pharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1006\/bbrc.1999.1003","article-title":"Gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide: Down-regulation of nitric oxide synthase-2 and caspase-3 by sulglycotide","volume":"261","author":"Slomiany","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_27","first-page":"238","article-title":"Effect of smoking on failure of H. pylori therapy and gastric histology in a high gastric cancer risk area of Colombia","volume":"37","author":"Camargo","year":"2007","journal-title":"Acta Gastroenterol. Latinoam."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.amjmed.2005.10.003","article-title":"Smoking increases the treatment failure for Helicobacter pylori eradication","volume":"119","author":"Suzuki","year":"2006","journal-title":"Am. J. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"164","DOI":"10.5662\/wjm.v5.i3.164","article-title":"Prevalence of antibiotic resistance in Helicobacter pylori: A recent literature review","volume":"5","author":"Ghotaslou","year":"2015","journal-title":"World J. Methodol."},{"key":"ref_30","first-page":"409","article-title":"Worldwide H. pylori antibiotic resistance: A systematic review","volume":"19","author":"Giorgio","year":"2010","journal-title":"J. Gastrointest. Liver Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/ni.3202","article-title":"The receptor NLRP3 is a transcriptional regulator of TH2 differentiation","volume":"16","author":"Bruchard","year":"2015","journal-title":"Nat. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1158\/1541-7786.MCR-05-0261","article-title":"Inflammation, a key event in cancer development","volume":"4","author":"Lu","year":"2006","journal-title":"Mol. Cancer Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/jcb.24389","article-title":"Role of the Helicobacter pylori-induced inflammatory response in the development of gastric cancer","volume":"114","author":"Lamb","year":"2013","journal-title":"J. Cell. Biochem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ccr.2008.10.011","article-title":"Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice","volume":"14","author":"Tu","year":"2008","journal-title":"Cancer Cell"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/35006081","article-title":"Interleukin-1 polymorphisms associated with increased risk of gastric cancer","volume":"404","author":"Carrington","year":"2000","journal-title":"Nature"},{"key":"ref_36","first-page":"345","article-title":"Suppression of Helicobacter pylori protease activity towards growth factors by sulglycotide","volume":"48","author":"Piotrowski","year":"1997","journal-title":"J. Physiol. Pharmacol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1053\/j.gastro.2009.01.073","article-title":"Helicobacter pylori in health and disease","volume":"136","author":"Cover","year":"2009","journal-title":"Gastroenterology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1750-9378-9-43","article-title":"Inhibitory effect of piperine on Helicobacter pylori growth and adhesion to gastric adenocarcinoma cells","volume":"9","author":"Tharmalingam","year":"2014","journal-title":"Infect. Agents Cancer"}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/17\/8\/2918\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:45:18Z","timestamp":1760363118000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/17\/8\/2918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,23]]},"references-count":38,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,4]]}},"alternative-id":["ijerph17082918"],"URL":"https:\/\/doi.org\/10.3390\/ijerph17082918","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,23]]}}}